Literature DB >> 22454868

Prescribing aids for gentamicin.

G E Mawer1, R Ahmad, S M Dobbs, J G McGough, S B Lucas, J A Tooth.   

Abstract

1 A nomogram and a digital computer program have been developed to calculate dosage schedules of gentamicin for individual patients. The minimum input data consist of the patients' age, sex, body weight and serum creatinine concentration. 2 These prescribing aids have been evaluated in 36 patients with severe Gram negative infections. Renal function ranged from normal to complete anuria. Nomogram dosage schedules gave serum concentrations of gentamicin within the chosen therapeutic limits. Physician dosage schedules gave serum concentrations which sometimes exceeded and sometimes fell below these limits. The validity of the computer program was demonstrated by its ability to predict serum concentrations of gentamicin whatever the dosage schedule. 3 Half the patients recovered from the bacterial infection but seven remained infected and eleven died. Pseudomonas aeruginosa was the most difficult organism to eradicate. 4 Four of the patients who survived developed ataxia and two developed hearing loss at high frequencies. The risk of ototoxicity was a function of mean trough serum gentamicin concentration and duration of treatment. Ototoxicity was only detected in patients with serum creatinine concentrations above 3 mg/100 ml who tended to have higher trough concentrations. When treatment was prolonged beyond 8-10 days the risk of ototoxicity was increased without evidence of further substantial therapeutic benefit.

Entities:  

Year:  1974        PMID: 22454868      PMCID: PMC1402410          DOI: 10.1111/j.1365-2125.1974.tb00205.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  5 in total

1.  Nomogram for kanamycin dosage.

Authors:  G E Mawer; S B Lucas; J G McGough
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

2.  Computer-assisted prescribing of kanamycin for patients with renal insufficiency.

Authors:  G E Mawer; S B Lucas; B R Knowles; R M Stirland
Journal:  Lancet       Date:  1972-01-01       Impact factor: 79.321

Review 3.  Iatrogenic deafness.

Authors:  J Ballantyne
Journal:  J Laryngol Otol       Date:  1970-10       Impact factor: 1.469

4.  Serum streptomycin levels and dizziness.

Authors:  D H Line; G W Poole; P M Waterworth
Journal:  Tubercle       Date:  1970-03

5.  Drug dosage in patients with impaired renal function.

Authors:  L Dettli; P Spring; R Habersang
Journal:  Postgrad Med J       Date:  1970-10       Impact factor: 2.401

  5 in total
  14 in total

1.  1974-2014: Reflections on the evolution of clinical pharmacology in the past 40 years and a message to our readers.

Authors:  James M Ritter
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

2.  Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.

Authors:  R J Sawchuk; D E Zaske
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

Review 3.  Cost-effectiveness of therapeutic drug monitoring.

Authors:  S Vozeh
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

5.  Accumulation in the peripheral compartment of a linear two-compartment open model.

Authors:  I Gonda; E S Harpur
Journal:  J Pharmacokinet Biopharm       Date:  1980-02

6.  Comparison of non-kinetic and kinetic approaches to individualization of gentamicin dosage.

Authors:  Y M el-Sayed; S I Islam
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 7.  Computer assisted prescribing of drugs.

Authors:  G E Mawer
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

8.  Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.

Authors:  L A Bauer; R A Blouin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 9.  An updated comparison of drug dosing methods. Part III: Aminoglycoside antibiotics.

Authors:  S M Erdman; K A Rodvold; R D Pryka
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

10.  Multicompartment pharmacokinetics of netilmicin.

Authors:  M Wenk; P Spring; S Vozeh; F Follath
Journal:  Eur J Clin Pharmacol       Date:  1979-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.